In a collaborative study, investigators have implemented advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.
Investigators found that patients with Crohn’s disease have an overabundance of an inflammation-producing gut bacteria. A metabolite produced by this bacteria interacts with the immune system cells in the lining of the intestine.
Dr. Scherl’s distinguished career and pioneering advances in IBD were celebrated in a virtual event with research collaborators, medical colleagues, the families of patients, and friends.
The award provides early-career scientists with $500,000 over five years to investigate the interplay between humans and pathogens, and how such encounters can lead to disease.
Dr. Gregory F. Sonnenberg has been recognized for his “innovative research program which continues to make seminal scientific contributions at the interface of immunology and microbiology.”
The WDOM congratulates three of its faculty - Drs. Julie Magarian Blander, Robert Peck, and Erica Phillips - who received grants from Weill Cornell Medicine in support of their innovative research on COVID-19.
A development program for junior faculty, LAMP provides participants with critical tools to accomplish their primary career goals as academicians in the field of medicine.
The paper is a one-year retrospective review of the incidence of Clostridium difficile infection in NewYork-Presbyterian/Weill Cornell Medical Center inpatients.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.
Fecal microbiota transplant has been shown in some studies to promote healing in the mucosal lining of the lower digestive tract, thus relieving ulcerative colitis symptoms in some people.
